Foreigners flee China stocks, pull out a record $2.5 billion, as panic spreads

Panic selling hit markets on Monday following the nation’s twice-a-decade political event, with the Hang Seng China Enterprises Index tumbling to the lowest level since the 2008 financial crisis. President Xi Jinping’s consolidation of power was seen as a major risk, with expectations that the leadership reshuffle would bring a continuation of key policies like Covid Zero

Bloomberg

October 25, 2022 / 06:39 IST

Foreign investors are on track to turn sellers of Chinese equities for the first time ever for the year, as concerns about a lack of supportive policies from the Party congress and a renewed Covid Zero push spook markets.

Overseas investors sold a record net 17.9 billion yuan ($2.5 billion) of mainland shares via trading links with Hong Kong on Monday, according to Bloomberg data, tipping the year-to-date level into a small net outflow. If that holds through year end, it would be the first annual decline since the stock connect program was launched in 2014.

Panic selling hit markets on Monday following the nation’s twice-a-decade political event, with the Hang Seng China Enterprises Index tumbling to the lowest level since the 2008 financial crisis. President Xi Jinping’s consolidation of power was seen as a major risk, with expectations that the leadership reshuffle would bring a continuation of key policies like Covid Zero.

“Foreign sentiment on Chinese stocks is low now,” as the party congress signaled no imminent changes to Covid policies, said Marvin Chen, an analyst with Bloomberg Intelligence. “Markets may need to wait to closer to the Central Economic Work Conference in December to see how the new leadership will address China’s economic challenges.”

China bears are growing by the day as traders turn skeptics of the nation’s economic growth prospects hampered by Covid Zero and the heavily battered property sector. The benchmark CSI 300 Index dropped 2.9% on Monday amid the broader selloff despite the nation posting better-than-expected third quarter gross domestic product data.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show